Lombard Odier Asset Management (Switzerland) Sa Abbott Laboratories Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

A detailed history of Lombard Odier Asset Management (Switzerland) Sa transactions in Abbott Laboratories stock. As of the latest transaction made, Lombard Odier Asset Management (Switzerland) Sa holds 42,752 shares of ABT stock, worth $5.01 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

42,752

Previous 39,281 8.84%

Holding current value

$5.01 Million

Previous $4.08 Million 19.43%

% of portfolio

0.43%

Previous 0.42%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $347,342 - $410,029	3,471 Added 8.84%	42,752 $4.87 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $9.27 Million - $10.3 Million	-92,047 Reduced 70.09%	39,281 $4.08 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.87 Million - $2.07 Million	17,085 Added 14.95%	131,328 $14.9 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $9.29 Million - $11.4 Million	103,039 Added 919.66%	114,243 $12.6 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $7,961 - $8,870	79 Added 0.71%	11,204 $1.22 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $14.3 Million - $16.9 Million	-148,038 Reduced 93.01%	11,125 $1.13 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $121,486 - $142,522	1,278 Added 0.81%	159,163 $17.5 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.05 Million - $1.22 Million	-10,892 Reduced 6.45%	157,885 $15.3 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $1.15 Million - $1.39 Million	11,285 Added 7.17%	168,777 $18.3 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $15 Million - $18.2 Million	-131,162 Reduced 45.44%	157,492 $18.6 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $9.15 Million - $11.2 Million	79,180 Added 37.8%	288,654 $40.6 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $2.93 Million - $3.24 Million	-25,140 Reduced 10.72%	209,474 $24.7 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $3.93 Million - $4.63 Million	37,194 Added 18.84%	234,614 $27.2 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $3.51 Million - $4.13 Million	32,228 Added 19.51%	197,420 $23.7 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $560,070 - $610,316	-5,334 Reduced 3.13%	165,192 $18.1 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $391,394 - $475,319	4,271 Added 2.57%	170,526 $18.6 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $5.18 Million - $6.63 Million	-67,636 Reduced 28.92%	166,255 $15.2 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $239,972 - $350,905	3,820 Added 1.66%	233,891 $18.5 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $2.62 Million - $2.91 Million	-33,332 Reduced 12.65%	230,071 $20 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $134,217 - $145,533	-1,640 Reduced 0.62%	263,403 $22 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $3.54 Million - $4.13 Million	48,599 Added 22.45%	265,043 $22.3 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $4.64 Million - $5.6 Million	-70,000 Reduced 24.44%	216,444 $17.3 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $258,568 - $292,920	-3,944 Reduced 1.36%	286,444 $20.7 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $2.06 Million - $2.49 Million	33,944 Added 13.24%	290,388 $21.3 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $272,651 - $300,925	-4,736 Reduced 1.81%	256,444 $15.6 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $14.2 Million - $16.1 Million	252,771 Added 3005.96%	261,180 $15.7 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $404,136 - $451,058	8,409	8,409 $449,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account

Lombard Odier Asset Management (Switzerland) Sa Abbott Laboratories Transaction History